Klouche M - Search Results

1

IL-6 receptor independent stimulation of human gp130 by viral IL-6.

Müllberg J, Geib T, Jostock T, Hoischen SH, Vollmer P, Voltz N, Heinz D, Galle PR, Klouche M, Rose-John S. Müllberg J, et al. Among authors: klouche m. J Immunol. 2000 May 1;164(9):4672-7. doi: 10.4049/jimmunol.164.9.4672. J Immunol. 2000. PMID: 10779772

2

Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor.

Klouche M, Bhakdi S, Hemmes M, Rose-John S. Klouche M, et al. J Immunol. 1999 Oct 15;163(8):4583-9. J Immunol. 1999. PMID: 10510402

3

Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells.

Klouche M, Brockmeyer N, Knabbe C, Rose-John S. Klouche M, et al. AIDS. 2002 May 24;16(8):F9-18. doi: 10.1097/00002030-200205240-00001. AIDS. 2002. PMID: 12004288

4

Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation.

Klouche M, Rose-John S, Schmiedt W, Bhakdi S. Klouche M, et al. Circulation. 2000 Apr 18;101(15):1799-805. doi: 10.1161/01.cir.101.15.1799. Circulation. 2000. PMID: 10769280

5

Virokines in the pathogenesis of cancer: focus on human herpesvirus 8.

Klouche M, Carruba G, Castagnetta L, Rose-John S. Klouche M, et al. Ann N Y Acad Sci. 2004 Dec;1028:329-39. doi: 10.1196/annals.1322.038. Ann N Y Acad Sci. 2004. PMID: 15650258 Review.

6

Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers.

Klouche M, May AE, Hemmes M, Messner M, Kanse SM, Preissner KT, Bhakdi S. Klouche M, et al. Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):784-93. doi: 10.1161/01.atv.19.3.784. Arterioscler Thromb Vasc Biol. 1999. PMID: 10073987

7

Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation.

Bhakdi S, Torzewski M, Klouche M, Hemmes M. Bhakdi S, et al. Among authors: klouche m. Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2348-54. doi: 10.1161/01.atv.19.10.2348. Arterioscler Thromb Vasc Biol. 1999. PMID: 10521363

8

Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages.

Klouche M, Gottschling S, Gerl V, Hell W, Husmann M, Dorweiler B, Messner M, Bhakdi S. Klouche M, et al. Arterioscler Thromb Vasc Biol. 1998 Sep;18(9):1376-85. doi: 10.1161/01.atv.18.9.1376. Arterioscler Thromb Vasc Biol. 1998. PMID: 9743225

9

Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells.

Klouche M, Peri G, Knabbe C, Eckstein HH, Schmid FX, Schmitz G, Mantovani A. Klouche M, et al. Atherosclerosis. 2004 Aug;175(2):221-8. doi: 10.1016/j.atherosclerosis.2004.03.020. Atherosclerosis. 2004. PMID: 15262177

10

Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.

Kreuter A, Rasokat H, Klouche M, Esser S, Bader A, Gambichler T, Altmeyer P, Brockmeyer NH. Kreuter A, et al. Among authors: klouche m. Cancer Invest. 2005;23(8):653-9. doi: 10.1080/07357900500358259. Cancer Invest. 2005. PMID: 16377582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters